KALA BIO, Inc. funding
KALA BIO, Inc., a pharmaceuticals company based in Arlington, MA, filed a Form D with the SEC on March 17, 2026 and reported $1.8M raised. It filed 2 new offerings in this period, totaling $4M.
Amount raised$1.8M
Offering size$1.8M
Filed with the SECMarch 17, 2026
First saleMarch 3, 2026
IndustryPharmaceuticals
SecuritiesEquity
LocationArlington, MA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far1
Minimum investment$1.8M
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Mar 17
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| March 17, 2026 | $1.8M | $1.8M | Equity |
| February 13, 2026 | $2.3M | $4.2M | Equity |
Other health care rounds in Massachusetts
Zai Lab Ltd$250M · Nov 9BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21BiotechnologyAI3 Bio, Inc.$48.3M · Nov 4BiotechnologyNanopath Inc$29.9M · Nov 13BiotechnologyXRHealth, Inc.$22.8M · Sep 16Other Health CareXact Bio, Inc.$10M · Sep 28BiotechnologyCrosslink Therapeutics Inc.$5.5M · Oct 20PharmaceuticalsFresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care